News | Digital Radiography (DR) | January 27, 2020

Flat Panel Medical X-Ray Detectors Outperforming CR, CCD and Analog Counterparts

2019 analysis and review of medical X-ray detectors market by product - indirect flat-panel detectors, direct flat-panel detectors, and computed radiography (CR) detectors for 2019 - 2029

Rayence C-Series wireless DR detector

Image courtesy of Rayence

January 27, 2020 — The expansion of medical imaging and diagnostics sector over the recent past has augured well for the sales of medical X-ray detectors at a global level. The global medical X-ray detectors market, surpassing a billion-dollar revenues in 2019, is set for a promising CAGR during 2019-2029.

The medical devices industry is observing a growth in number of imaging and diagnostic tests performed every year, owing to numerous factors such as increasing focus on radiological diagnostic tests, increasing chronic diseases burden, and introduction of efficient X-ray devices through consolidation and mergers in the medical devices market. Growing incidence of sports injuries, trauma and cancer represents a significant patient pool opting diagnostic imaging tests annually, particularly in emerging countries.

The Centers for Disease Control & Prevention (CDC) estimates that around 80 million computed tomography (CT) tests were performed in 2015 in the U.S. alone. Rise in number of patients undergoing CT and radiography tests globally and increase in number of tests performed each year have led to significant demand for digital radiography detectors such as a-Si detectors. These factors have boosted the demand for a-Si X-ray flat panel detectors, directly fueling growth of the medical X-ray detectors market.

 

Key Takeaways - Medical X-ray Detectors Market Study

  • Adoption of flat panel X-ray detectors in the global medical X-ray detectors market has increased significantly owing to distinct benefits over computed radiography (CR), charged couple detectors (CCD), and analog detectors (film based).
  • Introduction of new technology such as Veradius X–ray system by manufacturers is expected to boost demand for thin flat detector devices and computed radiography (CR) detectors among end users.
  • Direct flat-panel medical X-ray detectors with comparatively higher technical advantage over indirect flat-panel medical X-ray detectors are expected to generate significant revenue.
  • Increasing adoption of digital X-ray systems for radiological imaging as compared to retrofit X-ray systems marks high revenue potential for the medical X-ray detectors market.

 

Strategic Acquisitions Remains Favored Competition Strategy

Leading players in the medical X-ray detectors market such as GE Healthcare, Canon, Philips, and Hitachi, are focusing on business expansions by entering into partnership, merger, sales agreement and acquisition with local manufacturers from emerging economies. The aim behind these mergers and acquisitions is to reduce the product development cost, streamline the distribution channel, and strengthen the market position.

In December 2016, Canon Inc. acquired Toshiba Corp. medical unit. With the acquisition, Canon Inc. entered into diagnostics imaging devices market and leverage the core strength of Toshiba Medicals in diagnostic imaging. This acquisition would further strengthen Canon’s biomedical business.

Additionally, key players are focusing on research and development and launch of new products based on exclusive developmental technologies, with emphasis on product difference. In November 2017, at the Radiological Society of North America (RSNA) tradeshow. Carestream Health showcased a mobile X-ray system with carbon nanotube. The system entered the medical X-ray detectors market in May 2018 and is compatible with every DRX a-Si detector device providers by Carestream Health.

These insights are based on a report Medical X-Ray Detectors Market by Future Market Insights.

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 U.S. Surgeon General Jerome Adams, M.D., M.Ph demonstrates how the general public can make their own face masks for non-clinical use.

U.S. Surgeon General Jerome Adams, M.D., M.Ph. demonstrates how the general public can make their own face masks for non-clinical use.

News | Coronavirus (COVID-19) | April 04, 2020 | By Melinda Taschetta-Millane
April 4, 2020 — The Centers for Disease Control and Prevention (CDC)
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
Jeannie Danker, M.D. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Jeannie Danker, M.D. Photo courtesy of The Ohio State University Wexner Medical Center

News | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane
April 3, 2020 — The radiology world has lost a dedicated leader due to...
An estimated 44 million people worldwide are currently living with Alzheimer’s disease, the most common form of dementia. About 5.8 million people in the United States live with the disease, where it is the sixth leading cause of death overall. While there is not yet a cure for Alzheimer’s, researchers are working to find treatment options to delay its onset and prevent it from developing.

Image courtesy of Insightec

Feature | Ultrasound Imaging | April 02, 2020 | By Katie Caron
An estimated 44 million people worldwide are currently living with...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

News | Ultrasound Imaging | April 02, 2020
April 2, 2020 — Esaote, an Italian company among the world leader
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Updated CT scoring criteria from AJR considers both lobe involvement and changes in CT findings to quantitatively and accurately evaluate the progression of COVID-19 pneumonia

CT scoring criteria were applied to images from sequential chest CT examinations. A, Initial chest CT image obtained 2 days after onset of symptoms shows small region of subpleural ground-glass opacities in right lower lobe, for CT score of 1. B, Chest CT image obtained on day 3 of treatment shows slightly enlarged region of subpleural ground-glass opacities with partial crazy-paving pattern and consolidation, for CT score of 3. C, Chest CT image obtained on day 5 of treatment shows partial resolution of consolidation, for CT score of 2. D, Chest CT image obtained on day 14 of treatment shows continued resolution of consolidation with minimal residual ground-glass opacities, for CT score of 1. Image courtesy of American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 02, 2020
April 2, 2020 — Updated computed t...